Adtran, Inc. (ADTN) Tops Q3 EPS by 3c; Authorizes Additional 5M Common Buyback
Tweet
Share
E-mailGet Alerts ADTN Hot Sheet
Price: $8.07 -1.1%
Financial Fact:
Other expense, net: -246K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Other expense, net: -246K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Adtran, Inc. (NASDAQ: ADTN) reported Q3 EPS of $0.59, ex-items, $0.03 better than the analyst estimate of $0.56. Revenue for the quarter came in at $192.19 million versus the consensus estimate of $189.44 million.
The Company announced that its Board of Directors has authorized the repurchase of an additional 5,000,000 shares of the Company’s common stock to commence upon completion of the repurchase plan announced April 14, 2008.
The Company announced that its Board of Directors has authorized the repurchase of an additional 5,000,000 shares of the Company’s common stock to commence upon completion of the repurchase plan announced April 14, 2008.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TEC reduces pressure on support teams with proactive outage communications powered by Adtran and GOCare
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Stock BuybacksSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
